The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

The product was developed using STEERLife's FragMelt continuous processing platform, which enables solvent-free manufacturing while maintaining bioequivalence to the reference product.

Bionpharma's etravirine tablet for HIV/AIDS, developed on a continuous manufacturing platform, got Abbreviated New Drug ...

The "Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course (Feb 11th - Feb 12th, 2026)" training has been added to ResearchAndMarkets.com's offering.

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Join us Jan. 14 for a virtual discussion about our Rx ...

Felixvet's meloxicam oral suspension is bioequivalent to Metacam. A generic product for managing pain and inflammation associated with osteoarthritis (OA) in canines has been approved by FDA officials ...

A generic drug lobbying group reached an agreement with Connecticut that would halt litigation over a state drug pricing law, making the latest turn in a slew of battles over states’ attempts to rein ...

IQVIA Holdings is positioned as the indispensable data and technology backbone of the life sciences industry, far beyond a traditional CRO. Long-term revenue visibility is underpinned by a record ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Your device does not support the audio. CHICAGO – Attorney General Kwame Raoul announced that a court dismissed a motion for summary judgment filed by the drugmakers seeking to toss key elements of an ...

The motion comes as class action attorneys are grappling with the advent of third parties that, through the use of technology, have advertised their services to assist potential class members in ...

Introduction: Non-clinical immunogenicity yields valuable insights into pharmacokinetics, efficacy, and safety. Given the complex nature of ADC therapeutics, early detection of anti-drug antibodies ...